Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scheid, M. P.
Right arrow Articles by Duronio, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scheid, M. P.
Right arrow Articles by Duronio, V.
Related Collections
Right arrow Immunobiology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, Vol. 93 No. 1 (January 1), 1999: pp. 217-225

Ceramide and Cyclic Adenosine Monophosphate (cAMP) Induce cAMP Response Element Binding Protein Phosphorylation via Distinct Signaling Pathways While Having Opposite Effects on Myeloid Cell Survival

Michael P. Scheid, Ian N. Foltz, Peter R. Young, John W. Schrader, and Vincent Duronio

From the Department of Medicine and The Biomedical Research Centre, University of British Columbia and Vancouver Hospital and Health Sciences Centre, Vancouver, Canada; and SmithKline Beecham, King of Prussia, PA.

The role of ceramide as a second messenger is a subject of great interest, particularly since it is implicated in signaling in response to inflammatory cytokines. Ceramide induces apoptosis in both cytokine-dependent MC/9 cells and factor-independent U937 cells. Elevation of cyclic adenosine monophosphate (cAMP) levels inhibits apoptosis induced by ceramide and several other treatments. One target of cAMP-mediated signaling is the transcription factor CREB (cAMP response element binding protein), and recently CREB phosphorylation at an activating site has been shown to also be mediated by a cascade involving p38 mitogen-activated protein kinase (MAPK), one of the stress-activated MAP kinases. Because no role for p38 MAPK in apoptosis has been firmly established, we examined the relationship between p38 MAPK and CREB phosphorylation under various conditions. Ceramide, or sphingomyelinase, like tumor necrosis factor-alpha (TNF-alpha ) or the hematopoietic growth factor, interleukin-3 (IL-3), was shown to activate p38 MAPK, which in turn activated MAPKAP kinase-2. Each of these treatments led to phosphorylation of CREB (and the related factor ATF-1). A selective p38 MAPK inhibitor, SB203580, blocked TNF-alpha - or ceramide-induced CREB phosphorylation, but had no effect on the induction of apoptosis mediated by these agents. The protective agents cAMP and IL-3 also led to CREB phosphorylation, but this effect was independent of p38 MAPK, even though IL-3 was shown to activate both p38 MAPK and MAPKAP kinase-2. Therefore, the opposing effects on apoptosis observed with cAMP and IL-3, compared with ceramide and TNF-alpha , could not be explained on the basis of phosphorylation of CREB. In addition, because SB203580 had no effect of TNF-alpha or ceramide-induced apoptosis, our results strongly argue against a role for p38 MAPK in the induction of TNF-alpha - or ceramide-induced apoptosis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
K. M. Sakamoto and D. A. Frank
CREB in the Pathophysiology of Cancer: Implications for Targeting Transcription Factors for Cancer Therapy
Clin. Cancer Res., April 15, 2009; 15(8): 2583 - 2587.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. H. Chen, M. Riazy, E. M. Smith, C. G. Proud, U. P. Steinbrecher, and V. Duronio
Oxidized LDL-Mediated Macrophage Survival Involves Elongation Factor-2 Kinase
Arterioscler. Thromb. Vasc. Biol., January 1, 2009; 29(1): 92 - 98.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. Morales, I. Gonzalez-Robayna, M. P. Santana, I. Hernandez, and L. F. Fanjul
Tumor Necrosis Factor-{alpha} Activates Transcription of Inducible Repressor Form of 3',5'-Cyclic Adenosine 5'-Monophosphate-Responsive Element Binding Modulator and Represses P450 Aromatase and Inhibin {alpha}-Subunit Expression in Rat Ovarian Granulosa Cells by a p44/42 Mitogen-Activated Protein Kinase-Dependent Mechanism
Endocrinology, December 1, 2006; 147(12): 5932 - 5939.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E.-Y. Moon and A. Lerner
PDE4 inhibitors activate a mitochondrial apoptotic pathway in chronic lymphocytic leukemia cells that is regulated by protein phosphatase 2A
Blood, May 15, 2003; 101(10): 4122 - 4130.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
C. R. L. Webster, P. Usechak, and M. S. Anwer
cAMP inhibits bile acid-induced apoptosis by blocking caspase activation and cytochrome c release
Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G727 - G738.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q.-B. She, W.-Y. Ma, S. Zhong, and Z. Dong
Activation of JNK1, RSK2, and MSK1 Is Involved in Serine 112 Phosphorylation of Bad by Ultraviolet B Radiation
J. Biol. Chem., June 28, 2002; 277(27): 24039 - 24048.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
S J H van Deventer
Small therapeutic molecules for the treatment of inflammatory bowel disease
Gut, May 1, 2002; 50(90003): iii47 - 53.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Ghose, J. Fleming, K. El-Bayoumy, and P. R. Harrison
Enhanced Sensitivity of Human Oral Carcinomas to Induction of Apoptosis by Selenium Compounds: Involvement of Mitogen-activated Protein Kinase and Fas Pathways
Cancer Res., October 1, 2001; 61(20): 7479 - 7487.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
W. Chen, Y.-L. Yu, S.-F. Lee, Y.-J. Chiang, J.-R. Chao, J.-H. Huang, J.-H. Chiong, C.-J. Huang, M.-Z. Lai, H.-F. Yang-Yen, et al.
CREB Is One Component of the Binding Complex of the Ces-2/E2A-HLF Binding Element and Is an Integral Part of the Interleukin-3 Survival Signal
Mol. Cell. Biol., July 15, 2001; 21(14): 4636 - 4646.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Qian, G. Yehia, C. A. Molina, A. Fernandes, R. J. Donnelly, D. J. Anjaria, P. Gascon, and P. Rameshwar
Cloning of Human Preprotachykinin-I Promoter and the Role of Cyclic Adenosine 5'-Monophosphate Response Elements in Its Expression by IL-1 and Stem Cell Factor
J. Immunol., February 15, 2001; 166(4): 2553 - 2561.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
V. Maguer-Satta, R. Oostendorp, D. Reid, and C. J. Eaves
Evidence that ceramide mediates the ability of tumor necrosis factor to modulate primitive human hematopoietic cell fates
Blood, December 15, 2000; 96(13): 4118 - 4123.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Verploegen, J.-W. J. Lammers, L. Koenderman, and P. J. Coffer
Identification and characterization of CKLiK, a novel granulocyte Ca++/calmodulin-dependent kinase
Blood, November 1, 2000; 96(9): 3215 - 3223.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. A. J. Oostendorp, J. Audet, and C. J. Eaves
High-resolution tracking of cell division suggests similar cell cycle kinetics of hematopoietic stem cells stimulated in vitro and in vivo
Blood, February 1, 2000; 95(3): 855 - 862.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. P. Scheid, K. M. Schubert, and V. Duronio
Regulation of Bad Phosphorylation and Association with Bcl-xL by the MAPK/Erk Kinase
J. Biol. Chem., October 22, 1999; 274(43): 31108 - 31113.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1999 by American Society of Hematology         Online ISSN: 1528-0020